Happy New Year

December 29, 2017 16:01 ET | Source: Galapagos NV Galapagos NV

Happy New Year from the Investor Relations team:

Elizabeth Goodwin

Paul van der Horst

Evelyn Fox

Recommended Reading

January 05, 2026 16:01 ET | Source: Galapagos NV

Galapagos Announces Board Decision to Initiate Wind-Down of Cell Therapy Activities

Mechelen, Belgium; January 5, 2026, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced that the works council consultation process regarding the wind-down of cell therapy activities...
Read More
December 18, 2025 16:01 ET | Source: Galapagos NV

Galapagos Announces Topline Results from Two Phase 3-Enabling Studies with Selective TYK2 Inhibitor GLPG3667 in Dermatomyositis and Systemic Lupus Erythematosus

GLPG3667 met primary endpoint in dermatomyositis study, demonstrating a statistically significant clinical benefit and meaningful improvements on secondary measures of disease activity compared to...
Read More